All Type of News
Nano-fusion industry to become a new growth industry
The entire nano-fusion industry has become a new growth industry as recording approximately KRW 138.7 trillion sales in 2013, increased by 6.6% compared with the year before; for instance, sales of the nano-biomedical...
Bayer Korea, “Korea is a very potential market”Bayer Korea has shown expectation towards potential and co-development of the Korean life science market.
On the 27th, CEO Ingrid Drechsel of Bayer Korea stressed importance of...
|
Hanmi and Ildong’s high sales performance in the 3rd quarterHanmi Pharm and Ildong Pharmaceutical has made performance that is better than what they expected. Their representative products such as Amosartan and Aronamin have grown well, ...
|
Celltrion and Samsung Medison to record the highest market capitalization
It was observed market capitalization of listed companies in the health care industry reached KRW 152.2 trillion. Among pharmaceutical companies, Celltrion recorded the most with KRW 8.62 trillion; among medical devic...
Preemptive attack of Sanofi to launch Toujeo next month in novel basal insulin competition
Sanofi-Aventis has created a foundation to be a step ahead in the competition of a novel insulin against Novo Nordisk.
According to Sanofi, ‘Toujeo(generic name: insulin glargine),’ a next-generation once-daily long-...
Expectation in ‘complexes’ after erectile dysfunction treatments
Due to the generics launched after patent expirations of the original erectile dysfunction products, ‘Viagra(sildenafil)’ and ‘Cialis(tadalafil),’ generics have raged in the urology market.
Generic products, which ha...
Seoul with most doctors and Gwangju with most pharmacists
It was observed the patient-per-medical-personnel ratio was 180 physicians and 284 pharmacists per 100 thousand people in 2014.
According to the ‘2014 Annual Statistical Report of Regional Medical Use’ which was rece...
1 of 5 patients takes ‘medical trip’ to larger cities
A trend of patients to leave their residence to take medical treatment from hospitals in a large city has been fixed.
When it comes to the development of the past 4 years, in particular, it was observed the ratio of ...
The entry of Supect’s primary treatment is drawing near
‘Supect(ladotinib),’ a domestic new drug for chronic myeloid leukemia(CML), will soon become a primary treatment.
According to the industry concerned on the 27th, the indication expansion application which was turned...
Fueled Crestor generic market preoccupied by CJ and Ildong
In the market of ‘Crestor(rosuvastatin),’ a hyperlipidemia treatment which was jumped in by approximately 50 pharmaceutical companies last year, CJ HealthCare and Ildong Pharmaceutical have succeeded in getting a head...
